Session Chair Profile
Sr. Director Business Development, Edico Genome
Rebecca Hemenway is a precision medicine champion. As a serial intrepreneur, she is dedicated to bringing the world novel, cost effective and creative value-added healthcare solutions. Hemenway has conceptualized, commercialized and delivered innovative solutions at the intersect of clinical diagnostics, big genomic data and technology. Hemenway currently works as Sr. Director of Business Development at Edico Genome. Edico Genome is a San Diego-based startup that has developed the world’s first BioIT platform leveraging FPGA to accelerate and improve the accuracy of big genomic data. Previously, she has held various leadership positions at Illumina, Thermo Fisher and startups such as Helixis (acquired by Illumina) and Compendia Biosciences (acquired by Life Technologies). This provided Hemenway with both breadth and depth of industrial experience within early stage startups and globally recognized fortune 500 companies.
Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: As Next Generation Sequencing continues to outpace Moores Law it’s broad adoption in a clinical environment still faces several barriers to entry, namely complexity in workflow and reimbursement. To economically enable value based healthcare, technology providers need to think bigger and reimbursement needs to be more broadly understood and simplified. Come hear from our expert panelists about their thoughts on the current state of reimbursement, where things are moving and how individuals not directly involved in reimbursement can influence and expedite change.